University of Florida Health pediatric oncologist John A. Ligon, M.D., has been awarded a $600,000 grant from the V Foundation for Cancer Research to study a personalized immunotherapy vaccine to treat relapsed pediatric osteosarcoma.
In this episode, Stephanie Bailes, president and CEO of the Cade in Gainesville, Florida, shares how the Cade’s mission to transform communities by cultivating the inventive mindset.
In their quest to improve strawberry flavor, University of Florida scientists have found the genes behind several aromatic chemicals that enhance the fruit’s taste.
The COVID-19 pandemic’s impact on health care has made it more important than ever for nursing schools to educate the next generation of front-line providers. Now, thanks to an effort by Florida lawmakers to combat the nursing shortage, the University of Florida College of Nursing plans to build a “pipeline” to move well-prepared nurses into the workforce.
AMBY, which stands for AI Made By You, was piloted this summer as a part of Camp DIALOGS, an NSF-funded project aimed at making artificial intelligence and computer science more accessible, particularly for students in lower-income areas. The camp is a joint effort between UF’s Herbert Wertheim College of Engineering and College of Education and aligns with the university’s integrated approach to AI.
The fungus, Ganoderma zonatum, which causes the lethal disease known as Ganoderma butt rot of palms, shows few symptoms before you can detect something is wrong. Its mysterious nature has stunted research for decades, making early detection of the silent killer impossible – until now.
If you savor a juicy watermelon in the scorching summer heat, Florida farmers toil to meet your tastes. The Sunshine State leads the nation in watermelon production. But, like all farmers, those who produce watermelons seek ways to control diseases, so they don’t lose all or part of their crops. The needs of growers drive Yiannis Ampatzidis to use artificial intelligence to detect pathogens early and accurately.
In 2017, the US Food and Drug Administration (FDA) broke ground by approving the first drug with an embedded biosensor to track its use. The enthusiasm for digital approaches involving sensors, apps, and wearables that could transmit information across systems, commonly grouped under the term Internet of Things, also spread. Yet, despite the landmark FDA approval, digital pills have not exploded in pharma. Privacy and logistical concerns, especially while studying such applications for vulnerable populations, have lingered.
The University of Florida ranks No. 2 nationally among public universities and No. 4 among publics and privates for the economic return students get from attending college and leading students to greater financial security, according to a new analysis highlighted by Forbes magazine.
A major step toward transforming the understanding of cardiovascular and kidney disease in the millions of Americans with diabetes occurred Thursday when the National Institutes of Health designated the University of Florida Diabetes Institute the home of a new biobank of the human heart and kidney tissue.